Hedge fund exit puts Enovix under fresh scrutiny

Long Cast Advisors’ decision to exit Enovix (ENVX) after the departure of a key manufacturing process lead ahead of a major product launch has sharpened investor focus on the company’s execution risks.

The latest exit and management change come after a sharp 12.9% one day share price decline and 8.8% 7 day share price decline, despite a 50.1% 90 day share price return and a weaker 12 month total shareholder return. Together these moves suggest recent momentum is fading as investors reassess execution risk.

If this kind of volatility has you looking beyond a single stock, it could be a good moment to scan other battery and electrification plays through our 33 power grid technology and infrastructure stocks

With the stock down over the past year but still up 50.1% over 90 days, trading at US$7.28 against an analyst price target of US$13.10, is this volatility setting up a buying opportunity, or is the market already pricing in future growth?

Most Popular Narrative: 44.4% Undervalued

At a last close of $7.28 versus a narrative fair value of $13.10, Enovix is framed as materially undervalued, with the spotlight firmly on future growth execution.

Development and anticipated shipments of custom battery cells for smart eyewear devices and AR/VR markets starting mid-2025 create potential for higher margins due to premium pricing in these high-energy density applications. Ongoing advancements in next-generation battery models (EX-2M and EX-3M) and positive customer feedback on energy density performance suggest future earnings growth as these innovations meet evolving customer requirements and could enhance ASPs.

Want to see what sits behind that fair value gap and premium pricing story? The narrative leans on aggressive revenue compounding, margin expansion, and a punchy future profit multiple.

Result: Fair Value of $13.10 (UNDERVALUED)

However, stretched timelines for smartphone qualification and the cash demands of high volume manufacturing mean that delays or weaker demand could quickly challenge that undervaluation story.

Another way to look at it

That $13.10 fair value gap is built on analyst growth assumptions, but today’s pricing tells a different story. Enovix trades on a P/S ratio of 45.1x, compared with a US Electrical industry average of 2.4x, a peer average of 13.9x, and a fair ratio of 5.9x. For you, that raises a big question about how much optimism is already in the price.

Next Steps

The mix of concern and optimism around Enovix is clear, so move quickly and test the assumptions yourself by checking the 1 key reward and 1 important warning sign

Looking for more investment ideas?

If Enovix has sharpened your thinking, do not stop there. Broaden your watchlist now so you are not late to the next opportunity.

• Spot potential value early by scanning screener containing 22 high quality undiscovered gems that the market may not be paying full attention to yet.
• Target resilient balance sheets by reviewing the solid balance sheet and fundamentals stocks screener (46 results) for companies that might better handle bumps in the road.
• Prioritise stability and sleep a little easier by checking out 64 resilient stocks with low risk scores that align with a more cautious approach.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.